Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001). However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.

Cutaneous Adverse Events Related To Treatment With Imatinib

SAVOIA, Paola;FAVA, PAOLO
2014

Abstract

Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001). However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.
Imatinib: chemical stucture, pharmacology, adverse effects
Barbara J. Larsen Nova Science Publishers, Hauppauge, NY, AV.
1
81
87
9781628083040
melanoma; Imatinib mesylate
Savoia Paola; Fava Paolo
File in questo prodotto:
File Dimensione Formato  
978-1-62808-304-0_eBook Imatinib.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 3.6 MB
Formato Adobe PDF
3.6 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/142689
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact